from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1771/-

LFCtreatmentdescriptionclass of inhibitor

-1.035

Amikacinug/mL Amikacintranslation

-0.681

Cap5-10ug/mL Capreomycintranslation

-1.197

Rox10-50 ug/mL Roxithromycintranslation

-0.268

SM2-5 ug/mL Streptomycintranslation

-2.438

Tet5-10 ug/mL Tetracyclinetranslation

-0.469

Rif0.2-5ug/mL Rifampicintranscription

0.136

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.794

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.565

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.711

CPZ10-50 ug/mL Chlorpromazinerespiration

1.894

Clofazimine10-13 ug/mL Clofaziminerespiration

1.319

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.031

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.340

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.185

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.942

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.105

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.626

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.121

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.027

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.431

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.726

Nigericin50 uM Nigericinrespiration

0.094

TRC10-150 ug/mL Triclosanrespiration

2.196

TRZ10-25 ug/mL Thioridazinerespiration

-0.934

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.167

menadione6-10 ug/mL Menadionerespiration

-0.352

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.332

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.324

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.232

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.014

NRP_1Non-replicating persistence stage 1dosRassociated

0.719

Amp0.2mg/mL AmpicillincellWall

0.858

Cephalexin20-100 ug/mL CephalexincellWall

0.200

Cerulenin0.32-5 ug/mL CerulenincellWall

0.858

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.308

EMB10-20 ug/mL EthambutolcellWall

0.796

Eta12-40 ug/mL EthionamidecellWall

-0.016

INH0.2-0.4 ug/mL IsoniazidcellWall

0.672

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.927

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.705

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.188

BZA0.12 mg/mL BenzamidearomaticAmides

-0.194

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.851

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.260

H2O24 mM hydrogen peroxideDNAdamaging

0.527

Levo10 ug/mL LevofloxacinDNAdamaging

-0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.465

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.837

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.190

UVUV-irradiationDNAdamaging

0.764

ARP41-4 ug/mL Antitubercular compound ARP4?

0.363

Antimycin12.5-50 ug/mL Antimycin A?

-0.443

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.237

PA_110-50 ug/mL Antitubercular compound PA-1?

0.886

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.884

PA8240.2-2 ug/mL PA-824?

-1.084

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.291

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.743

Verapamil50 uM Verapamil?

-0.779

mercaptoethanol2 mM 2-Mercaptoethanol?

0.954

methoxatin10-20 ug/mL Methoxatin?